pH-responsive antibodies for therapeutic applications
Abstract Therapeutic antibodies are instrumental in improving the treatment outcome for certain disease conditions. However, to enhance their efficacy and specificity, many efforts are continuously made. One of the approaches that are increasingly explored in this field are pH-responsive antibodies...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Journal of Biomedical Science |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12929-021-00709-7 |
id |
doaj-a8f2bf41eccb4cbebf4e6ee2b081846d |
---|---|
record_format |
Article |
spelling |
doaj-a8f2bf41eccb4cbebf4e6ee2b081846d2021-01-24T12:22:24ZengBMCJournal of Biomedical Science1423-01272021-01-0128111410.1186/s12929-021-00709-7pH-responsive antibodies for therapeutic applicationsTomasz Klaus0Sameer Deshmukh1Research and Development Department, Pure Biologics, Inc.Research and Development Department, Pure Biologics, Inc.Abstract Therapeutic antibodies are instrumental in improving the treatment outcome for certain disease conditions. However, to enhance their efficacy and specificity, many efforts are continuously made. One of the approaches that are increasingly explored in this field are pH-responsive antibodies capable of binding target antigens in a pH-dependent manner. We reviewed suitability and examples of these antibodies that are functionally modulated by the tumor microenvironment. Provided in this review is an update about antigens targeted by pH-responsive, sweeping, and recycling antibodies. Applicability of the pH-responsive antibodies in the engineering of chimeric antigen receptor T-cells (CAR-T) and in improving drug delivery to the brain by the enhanced crossing of the blood–brain barrier is also discussed. The pH-responsive antibodies possess strong treatment potential. They emerge as next-generation programmable engineered biologic drugs that are active only within the targeted biological space. Thus, they are valuable in targeting acidified tumor microenvironment because of improved spatial persistence and reduced on-target off-tumor toxicities. We predict that the programmable pH-dependent antibodies become powerful tools in therapies of cancer.https://doi.org/10.1186/s12929-021-00709-7Antibody generationpH-responsive antibodiesRecycling antibodiesSweeping antibodiesTumor microenvironmentCAR-T cells |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tomasz Klaus Sameer Deshmukh |
spellingShingle |
Tomasz Klaus Sameer Deshmukh pH-responsive antibodies for therapeutic applications Journal of Biomedical Science Antibody generation pH-responsive antibodies Recycling antibodies Sweeping antibodies Tumor microenvironment CAR-T cells |
author_facet |
Tomasz Klaus Sameer Deshmukh |
author_sort |
Tomasz Klaus |
title |
pH-responsive antibodies for therapeutic applications |
title_short |
pH-responsive antibodies for therapeutic applications |
title_full |
pH-responsive antibodies for therapeutic applications |
title_fullStr |
pH-responsive antibodies for therapeutic applications |
title_full_unstemmed |
pH-responsive antibodies for therapeutic applications |
title_sort |
ph-responsive antibodies for therapeutic applications |
publisher |
BMC |
series |
Journal of Biomedical Science |
issn |
1423-0127 |
publishDate |
2021-01-01 |
description |
Abstract Therapeutic antibodies are instrumental in improving the treatment outcome for certain disease conditions. However, to enhance their efficacy and specificity, many efforts are continuously made. One of the approaches that are increasingly explored in this field are pH-responsive antibodies capable of binding target antigens in a pH-dependent manner. We reviewed suitability and examples of these antibodies that are functionally modulated by the tumor microenvironment. Provided in this review is an update about antigens targeted by pH-responsive, sweeping, and recycling antibodies. Applicability of the pH-responsive antibodies in the engineering of chimeric antigen receptor T-cells (CAR-T) and in improving drug delivery to the brain by the enhanced crossing of the blood–brain barrier is also discussed. The pH-responsive antibodies possess strong treatment potential. They emerge as next-generation programmable engineered biologic drugs that are active only within the targeted biological space. Thus, they are valuable in targeting acidified tumor microenvironment because of improved spatial persistence and reduced on-target off-tumor toxicities. We predict that the programmable pH-dependent antibodies become powerful tools in therapies of cancer. |
topic |
Antibody generation pH-responsive antibodies Recycling antibodies Sweeping antibodies Tumor microenvironment CAR-T cells |
url |
https://doi.org/10.1186/s12929-021-00709-7 |
work_keys_str_mv |
AT tomaszklaus phresponsiveantibodiesfortherapeuticapplications AT sameerdeshmukh phresponsiveantibodiesfortherapeuticapplications |
_version_ |
1724325922544287744 |